Accès gratuit
| Numéro |
Med Sci (Paris)
Volume 23, Mars 2007
Protéomique clinique en oncologie
|
|
|---|---|---|
| Page(s) | 27 - 30 | |
| Section | M/S revues | |
| DOI | https://doi.org/10.1051/medsci/2007231s27 | |
| Publié en ligne | 15 mars 2007 | |
- Hondermarck, H. (ed) (2004) Biomedical and Pharmaceutical Applications of Proteomics, Kluwer-Springer, Dordrecht, The Netherlands.ISBN: 1-4020-23 22–7. [Google Scholar]
- Hondermarck H. Breast cancer: when proteomics challenges biological complexity. Mol Cell. Proteomics 2003; 2 : 281–91. [Google Scholar]
- Celis JE, Moreira JM, Gromova I, et al. Towards discovery-driven translational research in breast cancer. FEBS J 2005; 272 : 2–15 [Google Scholar]
- Vercoutter-Edouart AS, Lemoine J, Le Bourhis X, et al. Proteomic analysis reveals that 14-3-3 sigma is down-regulated in human breast cancer cells. Cancer Res 2001; 61 : 76–80 [Google Scholar]
- Hermeking H. The 14-3-3 cancer connection. Nat Rev Cancer 2003;3 : 931–43 [Google Scholar]
- Descamps S, Toillon RA, Adriaenssens E, et al. Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J Biol Chem 2001;276 : 17864–70. [Google Scholar]
- Dollé L, El-Yazidi I, Adriaenssens E, et al. Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene 2003; 22 : 5592–601. [Google Scholar]
- Dolle L, Adriaenssens E, El Yazidi-Belkoura I, et al. Nerve growth factor receptors and signaling in breast cancer. Curr Cancer Drug Targets 2004;4 : 463–70 [Google Scholar]
- Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003; 422 : 198–207. [Google Scholar]
- Jensen ON. Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry. Curr Opin Chem Biol 2004; 8 : 33–41. [Google Scholar]
- Vandermoere F, El Yazidi-Belkoura I, Adriaenssens E, et al. The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-kappaB activation induced via interaction between Akt and IkappaB kinase-beta in breast cancer cells. Oncogene 2005;24 : 5482–91. [Google Scholar]
- Vandermoere F, El Yazidi-Belkoura I, Slomianny C, et al. The valosin containing protein (VCP) is a target of Akt signaling required for cell survival. J Biol Chem 2006; 281 : 14307–13. [Google Scholar]
- Vandermoere F, El-Yaridi-Belkoura I, Demont Y, et al. Proteomic exploration reveals that actin is a signaling target of the kinase Akt. Mol Cell Proteomics 2007; 6 : 114–24. [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.